Geode Capital Management LLC recently announced the acquisition of new stake in Soligenix Inc (NASDAQ:SNGX). The institutional investor has increased its shareholding in the Healthcare company by 139.92% to 50196.0 shares with purchase of 29274.0 shares. This fresh investment now brings its stake to 0.48% valued currently at $49192.0. In addition, XTX Markets LLC raised its holdings by 15077.0 to 15077.0 shares.
With over 6.96 million Soligenix Inc (SNGX) shares trading Monday and a closing price of $0.94 on the day, the dollar volume was approximately $6.54 million. The shares have shown a positive half year performance of 35.64% and its price on 01/08/24 gained nearly 16.68%. Currently, there are 10.38M common shares owned by the public and among those 10.34M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Soligenix Inc are iShares Core S&P Total US Stock M, Fidelity Extended Market Index Fu, and Vanguard Extended Market Index Fu. iShares Core S&P Total US Stock M owns 79537.0 shares of the company’s stock, all valued at over $77946.0. The company bought an additional 78422.0 shares recently to bring their total holdings to about 0.77% of the shares outstanding. Vanguard Extended Market Index Fu now owns shares totaling to 0.26% of the shares outstanding.
Shares of Soligenix Inc (NASDAQ: SNGX) opened at $0.90, up $0.09 from a prior closing price of $0.81. The company’s stock has a 5-day price change of 24.05% and 69.15% over the past three months. SNGX shares are trading 24.05% year to date (YTD), with the 12-month market performance down to -86.54% lower. It has a 12-month low price of $0.38 and touched a high of $8.10 over the same period. SNGX has an average intraday trading volume of 2.85 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 38.35%, 63.83%, and 20.30% respectively.
Institutional ownership of Soligenix Inc (NASDAQ: SNGX) shares accounts for 8.65% of the company’s 10.38M shares outstanding. Mutual fund holders own 1.53%, while other institutional holders and individual stakeholders account for 7.15% and 0.35% respectively.
It has a market capitalization of $9.75M and a beta (3y monthly) value of 1.82. The earnings-per-share (ttm) stands at -$2.04. Price movements for the stock have been influenced by the stock’s volatility, which stands at 23.28% over the week and 16.34% over the month.
Analysts forecast that Soligenix Inc (SNGX) will achieve an EPS of -$0.19 for the current quarter, -$0.2 for the next quarter and -$0.84 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.2 while analysts give the company a high EPS estimate of -$0.19. Comparatively, EPS for the current quarter was -$4.58 a year ago. Earnings per share for the fiscal year are expected to increase by 82.74%, and 9.64% over the next financial year. EPS should shrink at an annualized rate of 1.00% over the next five years, compared to 22.69% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 1 brokerage firm advisors rate Soligenix Inc (SNGX) as a “Strong Buy” at a consensus score of 1.00. Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”
